Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE™ Retrievable Vena Cava Filter, CLEANER™ Rotational Thrombectomy System, and UltraStream™ Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc. Prior to this transaction, the products were licensed and distributed by Argon through an exclusive agreement with Rex Medical. All three best-in-class product families have displayed significant growth under Argon’s leadership. The addition of these safe and proven technologies to […]
PLANO, Texas, May 6, 2014 /PRNewswire/ — Argon Medical Devices, Inc. announced today that the company has begun marketing the CLEANERXT™ Rotational Thrombectomy System as a new addition to the CLEANER family of dialysis products. With increased power and torque for cleaning wall-adherent thrombus, and the ability to be introduced through a 6 Fr sheath, CLEANERXT combines torque with trackability. Its innovative sinusoidal wire design is radiopaque and conforms to varying lumen diameters, actively cleaning wall-adherent thrombus.
Argon introduced the […]
Option™ELITE Retrievable Vena Cava Filter Receives FDA Clearance for a New Over-The-Wire Delivery Technique and Enters New Markets WorldwideFaisal Ali
PLANO, Texas, Jan. 16, 2014 /PRNewswire/ – Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the Option™ELITE retrievable inferior vena cava (IVC) filter with a new over-the-wire delivery technique. This new clearance enables physicians to safely deliver the filter to a patient’s IVC by following the path of a guidewire. The guidewire assists in keeping the filter centered in the IVC upon placement. The over-the-wire technique […]
Argon Medical Devices Announces The Launch Of OptionELITE Retrievable Vena Cava Filter And The Acquisition of Angiotech Interventional BusinessFaisal Ali
PLANO, Texas, April 4, 2013 /PRNewswire/ — Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (PE), Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter. The OptionELITE IVC Filter, designed by Rex Medical, LP, provides the clinician with the same safe and trusted design now enhanced for ease of delivery and retrievability.
“Safety and retrievability are without question two of the most vital, and […]
RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals’ Interventional Products BusinessFaisal Ali
LAKE FOREST, IL, MARCH 25, 2013 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon” or the “Company”), entered into a definitive agreement to acquire the Interventional Products Business of Angiotech Pharmaceuticals, Inc. (“Angiotech”). The Interventional Products Business manufactures and markets disposable and re-usable biopsy products for the diagnosis of cancer, drainage catheter products, and vascular interventional products. The transaction is […]
Plano, TX, January 16, 2013 – Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15™ Rotational Thrombectomy System. The addition of Cleaner15™ to Argon Medical’s product portfolio provides physicians with another weapon in their arsenal to safely and effectively restore patency in occluded arteriovenous fistulae and synthetic grafts.
“We are excited to introduce this leading-edge addition to the Cleaner line […]
LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, is pleased to announce that Argon Medical (LiDCO’s partner in Japan) has confirmed that the LiDCOrapid Monitor and associated disposable products have been successfully approved by the Japanese Ministry of Health, Labour and Welfare (MHLW). LiDCO believes that Japan is the second largest market in the world for hemodynamic monitoring with approximately 680,000 high-risk surgical patients per annum who would benefit clinically from improved intraoperative fluid management.
The LiDCO products will […]
PLANO, Texas, March 22, 2012 – Argon Medical Devices, Inc. announced today the US launch of the UltraStream Chronic Hemodialysis catheter, licensed from Rex Medical, LP, designed to provide long-term vascular access to patients receiving dialysis treatments.
“UltraStream provides clinicians with an innovative tool to improve care and quality of life for their patients,” commented George Leondis, President of Argon. “This unique technology broadens our dialysis platform and highlights our commitment to this growing disease state.”
The UltraStream Chronic Hemodialysis catheter […]
LiDCO signs LiDCOrapid monitor Registration and Supply Agreement for Japan with Argon Medical Devices Japan, K.K.Faisal Ali
LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, today announces that it has signed an agreement with Argon Medical Devices, Japan, K.K. (“Argon Medical”) to register with the Japanese Ministry of Health, Labour and Welfare the LiDCOrapid monitor and disposable kit for the Japanese market.
Argon Medical designs, manufactures and sells single-use specialty medical device disposables and in September 2010 acquired the critical care business of Becton, Dickinson (“BD”).
Dr Terry O’Brien,CEOof LiDCO, commented: “We are delighted to sign this […]
Argon Medical Devices Announces Exclusive License And Distribution Agreement For Option™ Retreivable Inferior Vena Cava FilterFaisal Ali
ATHENS, TX, March 15th, 2011 – Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP (“Rex Medical”) for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an implantable device used in the prevention of Pulmonary Embolism (PE).
“We are very pleased with the addition of Option™ to our product portfolio. This proven technology has rapidly become a leader in this disease segment due both […]